This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Tenet Healthcare Shares Punished

OKLAHOMA CITY -- Tenet Healthcare's (THC - Get Report) journey to the recovery room just got longer.

The Dallas-based hospital chain continued to make some progress in the quarter, swinging to a profit from a year-ago loss, but the company still fell short of Wall Street targets. It also scaled back its outlook for the full year and dropped a key promise for 2009, when it had hoped to prove its comeback by generating $1 billion in earnings before interest, taxes, depreciation and amortization.

While Tenet continues to attract more patients to its hospitals, with admissions now rising for the fourth quarter in a row, fewer of those patients enjoy generous health insurance coverage in the tough economy.

Shares of Tenet sunk more than 25% in recent trading to $3.06.

Other hospital stocks lost some ground as well. Community Health Systems (CYH - Get Report), the largest and strongest of the group, slipped 1% to $20.14. Universal Health Services (UHS - Get Report), a diversified hospital company with a strong presence in the behavioral health space, fell 2.3% to $43.18. Meanwhile, rural hospital operator LifePoint (LPNT - Get Report) tumbled 3.1% to $24.

Tenet said third-quarter revenue came in at $2.14 billion, up 5.2% from a year ago but still shy of the $2.21 billion consensus estimate. Similarly, net income soared to $104 million -- a clear improvement over the $59 million loss posted last year -- but included hefty gains from investments and other one-time benefits. Without that help, the company would have posted an operating loss of $32 million instead.
1 of 3

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
SYM TRADE IT LAST %CHG
CYH $62.65 0.00%
LPNT $87.36 0.00%
THC $59.42 0.00%
UHS $142.71 0.00%
AAPL $126.44 0.00%

Markets

DOW 17,730.11 -27.80 -0.16%
S&P 500 2,076.78 -0.64 -0.03%
NASDAQ 5,009.2140 -3.9090 -0.08%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs